BGC-101 (BioGenCell)

N/A

Report date: 2023/01/12 16:07:10

Base Information

Drug NameBGC-101 (BioGenCell)
Drug Alias NameBGC-101
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Endothelial progenitor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemiaPeripheral Vascular DiseasesPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiogencell Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiogencell Ltd
Inactive CompaniesN/A
Active IndicationsIschemiaPeripheral Vascular DiseasesPeripheral Arterial Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A